Clínica Baviera, S.A. (CBAV.MC)
EUR 36.4
(1.11%)
EUR 36.4
(1.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 224.92 Million EUR | 13.34% |
| 2022 | 198.44 Million EUR | 14.89% |
| 2021 | 172.73 Million EUR | 40.86% |
| 2020 | 122.62 Million EUR | -1.37% |
| 2019 | 124.33 Million EUR | 13.76% |
| 2018 | 109.29 Million EUR | 9.43% |
| 2017 | 99.87 Million EUR | 9.07% |
| 2016 | 91.57 Million EUR | 7.07% |
| 2015 | 85.52 Million EUR | 3.52% |
| 2014 | 82.62 Million EUR | 3.31% |
| 2013 | 79.97 Million EUR | -11.02% |
| 2012 | 89.88 Million EUR | -3.97% |
| 2011 | 93.59 Million EUR | 4.36% |
| 2010 | 89.68 Million EUR | 7.87% |
| 2009 | 83.14 Million EUR | -5.45% |
| 2008 | 87.93 Million EUR | 12.19% |
| 2007 | 78.38 Million EUR | 23.38% |
| 2006 | 63.52 Million EUR | 46.39% |
| 2005 | 43.39 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 65.12 Million EUR | 0.11% |
| 2024 Q1 | 66.4 Million EUR | 8.27% |
| 2023 Q3 | 47.67 Million EUR | -15.66% |
| 2023 Q2 | 56.52 Million EUR | -4.83% |
| 2023 Q1 | 59.39 Million EUR | 10.51% |
| 2023 Q4 | 61.33 Million EUR | 28.65% |
| 2023 FY | 224.92 Million EUR | 13.34% |
| 2022 Q2 | 50.24 Million EUR | -4.09% |
| 2022 FY | 198.44 Million EUR | 14.89% |
| 2022 Q4 | 53.74 Million EUR | 27.75% |
| 2022 Q3 | 42.06 Million EUR | -16.27% |
| 2022 Q1 | 52.39 Million EUR | 9.51% |
| 2021 Q1 | 41.2 Million EUR | 2.44% |
| 2021 FY | 172.73 Million EUR | 40.86% |
| 2021 Q4 | 47.84 Million EUR | 24.59% |
| 2021 Q3 | 38.39 Million EUR | -15.22% |
| 2021 Q2 | 45.29 Million EUR | 9.93% |
| 2020 Q4 | 40.21 Million EUR | 22.64% |
| 2020 Q2 | 20.2 Million EUR | -31.31% |
| 2020 FY | 122.62 Million EUR | -1.37% |
| 2020 Q3 | 32.79 Million EUR | 62.34% |
| 2020 Q1 | 29.4 Million EUR | -16.1% |
| 2019 Q3 | 27.22 Million EUR | -15.88% |
| 2019 Q1 | 29.69 Million EUR | -0.95% |
| 2019 Q2 | 32.36 Million EUR | 8.97% |
| 2019 Q4 | 35.05 Million EUR | 28.77% |
| 2019 FY | 124.33 Million EUR | 13.76% |
| 2018 Q1 | 28.5 Million EUR | 3.57% |
| 2018 Q3 | 23.14 Million EUR | -16.35% |
| 2018 FY | 109.29 Million EUR | 9.43% |
| 2018 Q4 | 29.98 Million EUR | 29.55% |
| 2018 Q2 | 27.66 Million EUR | -2.92% |
| 2017 Q2 | 25.33 Million EUR | 2.08% |
| 2017 FY | 99.87 Million EUR | 9.07% |
| 2017 Q4 | 27.51 Million EUR | 23.89% |
| 2017 Q3 | 22.21 Million EUR | -12.32% |
| 2017 Q1 | 24.81 Million EUR | 1.62% |
| 2016 Q1 | 24.29 Million EUR | -1.53% |
| 2016 FY | 91.57 Million EUR | 7.07% |
| 2016 Q4 | 24.42 Million EUR | 24.41% |
| 2016 Q3 | 19.63 Million EUR | -15.47% |
| 2016 Q2 | 23.22 Million EUR | -4.43% |
| 2015 Q4 | 24.67 Million EUR | 32.76% |
| 2015 Q1 | 21.77 Million EUR | -6.86% |
| 2015 Q2 | 20.48 Million EUR | -5.94% |
| 2015 Q3 | 18.58 Million EUR | -9.26% |
| 2015 FY | 85.52 Million EUR | 3.52% |
| 2014 Q4 | 23.38 Million EUR | 32.08% |
| 2014 Q2 | 19.78 Million EUR | -9.06% |
| 2014 Q1 | 21.75 Million EUR | 3.77% |
| 2014 FY | 82.62 Million EUR | 3.31% |
| 2014 Q3 | 17.7 Million EUR | -10.51% |
| 2013 Q1 | 24.23 Million EUR | -26.38% |
| 2013 Q3 | 16.67 Million EUR | -7.87% |
| 2013 Q4 | 20.96 Million EUR | 25.72% |
| 2013 FY | 79.97 Million EUR | -11.02% |
| 2013 Q2 | 18.09 Million EUR | -25.33% |
| 2012 Q2 | 22.6 Million EUR | -6.56% |
| 2012 Q3 | 10.17 Million EUR | -55.0% |
| 2012 FY | 89.88 Million EUR | -3.97% |
| 2012 Q1 | 24.18 Million EUR | 0.0% |
| 2012 Q4 | 32.92 Million EUR | 223.74% |
| 2011 FY | 93.59 Million EUR | 4.36% |
| 2010 FY | 89.68 Million EUR | 7.87% |
| 2009 FY | 83.14 Million EUR | -5.45% |
| 2008 FY | 87.93 Million EUR | 12.19% |
| 2007 FY | 78.38 Million EUR | 23.38% |
| 2006 FY | 63.52 Million EUR | 46.39% |
| 2005 FY | 43.39 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pangaea Oncology, S.A. | 7.99 Million EUR | -2712.127% |